References
- Dispenzieri A, Armitage JO, Loe MJ, Geyer SM, Allred J, Camoriano JK, et al. The clinical spectrum of Castleman's disease. Am J Hematol 2012;87:997-1002. https://doi.org/10.1002/ajh.23291
- Day JR, Bew D, Ali M, Dina R, Smith PL. Castleman's disease associated with myasthenia gravis. Ann Thorac Surg 2003;75:1648-1650. https://doi.org/10.1016/S0003-4975(02)04963-9
- Chorzelski T, Hashimoto T, Maciejewska B, Amagai M, Anhalt GJ, Jablonska S. Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans. J Am Acad Dermatol 1999;41:393-400. https://doi.org/10.1016/S0190-9622(99)70111-8
- Wang HW, Pittaluga S, Jaffe ES. Multicentric Castleman disease: where are we now? Semin Diagn Pathol 2016;33:294-306. https://doi.org/10.1053/j.semdp.2016.05.006
- Cheuk W, Chan JK. Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity. Semin Diagn Pathol 2012;29:226-234. https://doi.org/10.1053/j.semdp.2012.07.001
- Hurst RL, Gooch CL. Muscle-specific receptor tyrosine kinase (MuSK) myasthenia gravis. Curr Neurol Neurosci Rep 2016;16:61. https://doi.org/10.1007/s11910-016-0668-z
- Oh SJ. Muscle-Specific receptor tyrosine kinase antibody positive myasthenia gravis current status. J Clin Neurol 2009;5:53-64. https://doi.org/10.3988/jcn.2009.5.2.53
- Sylvester J, Purdie G, Slee M, Gray JX, Burnet S, Koblar S. Muscle-specific kinase antibody positive myaesthenia gravis and multiple sclerosis co-presentation: a case report and literature review. J Neuroimmunol 2013;264:130-133. https://doi.org/10.1016/j.jneuroim.2013.08.016